DOCSLIB.ORG

Rare Lung Disease Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rare Lung Disease Guide International Conference May 15 - May 20 DENVER COLORADO Rare Lung Disease Guide www.thoracic.org May 2015 Dear Colleagues, The scope of the American Thoracic Society is amazingly broad - covering pulmonary, critical care and sleep medicine. Our challenge each year as we put the International Conference program together is that some clinical topics that may be of central importance to our members, conference attendees and patients may not be prominently featured in the program each year. This is the case with rare lung diseases. With each challenge though, comes opportunity. Because of the wealth of scientific and clinical information presented at ATS 2014, these diseases, though uncommon, will be the focus of many presentations during the next several days. The purpose of this roadmap is to help you find these presentations. Irina Petrache, MD In his chapter on rare lung diseases in Breathing in America: Diseases, Progress, and Hope (2010), Francis X. McCormack, MD, noted that research on uncommon Indiana University respiratory diseases has produced some of the most exciting discoveries in pulmonary medicine. “Insights gained from uncommon lung diseases often shed light on more common ones.” ATS 2015 The definition of a rare disease by its prevalence varies by country. In the European Union, for instance, it is defined as a disease that affects fewer than 1 in 2,000, International while in the United States it is a disease that affects fewer than 1 in 200,000, at any given moment. The list of diseases included here was drawn from the NIH Center Conference Chair for Advancing Translational Sciences Office of Rare Lung Disease Research,* and from the work of a small group of ATS Members who studied the ATS 2015 Abstracts. Thanks to Dr. McCormack, Dr. Lisa Young, Dr. Jonathan Kropski, Dr. William Gower, Dr. Nishant Gupta, and Mr. Jack Kelly for their assistance with this resource. Despite pathogenic or clinical differences, rare diseases, including those in respiratory medicine, share common features. Many are serious, life-long, and debilitating. They tend to be misdiagnosed, at least initially and often for many years. Once identified, few have effective treatments. And when therapies are available, rare diseases are usually expensive to treat. Spurred by these challenges, the American Thoracic Society is particularly committed to helping patients with rare lung diseases. Many public interest organizations belonging to the ATS Public Advisory Roundtable represent patients with uncommon pulmonary diseases and make valuable contributions to our organization. Be sure to visit with them near ATS Center in the Exhibit Hall. With this guide, we invite health care professionals and patients interested in rare lung diseases to learn about the discoveries being presented during ATS 2015 that may change how we prevent or treat these diseases in the future and how this new knowledge may transform care for all respiratory patients. Sincerely, Irina Petrache, MD *http://rarediseases.info.nih.gov/gard/diseases-by-category/21/lung-diseases About This Guide: The list of search terms was developed using the American Thoracic Society’s Breathing in America and the Office of Rare Disease Research, National Institutes of Health Center for Advancing Translational Sciences, as content references. Due to the volume of content, Cystic Fibrosis and Idiopathic Pulmonary Fibrosis are not referenced in this guide. To look for additional search terms or content at ATS 2015 or the previous four years’ International Conference, visit http://conference.thoracic.org/2015/program/past-abstractprogram-search/. The following search terms from reference sites were used and returned no match for ATS 2014: Acropectorovertebral Dysplasia F Form Geroderma Osteodysplasticum Peroxisome Biogenesis Disorders Arterial Tortuosity Syndrome Glycosylphosphatidylinositol Deficiency Pulmonary Sequestration Cantu Syndrome Goodpasture Syndrome Pulmonary Venoocclusive Disease Coal Worker’s Pneumoconiosis Intrahepatic Cholestasis of Pregnancy Recurrent Respiratory Papillomatosis Congenital Lobar Emphysema Juvenile Dermatomyositis Salla Dsease Congenital Pulmonary Alveolar Proteinosis Kabuki Syndrome SCARF Syndrome Congenital Pulmonary Lymphangiectasia Kaolin Pneumoconiosis Sharp Syndrome Cornelia de Lange Syndrome Kartagener Syndrome Short Rib-Polydactyly Syndrome Type 1 Costocoracoid Ligament Congenitally Short Laryngoonychocutaneous Syndrome Short Rib-Polydactyly Syndrome Type 2 Cutis Laxa, Autosomal Recessive Type 1 Lethal Congenital Contracture Syndrome 1 Short Rib-Polydactyly Syndrome Type 3 Donnai-Barrow Syndrome Limited Scleroderma Short Rib-Polydactyly Syndrome Type 4 Eisenmenger Syndrome Loeys-Dietz Syndrome Simpson-Golabi-Behmel Syndrome Elastin Mutations Lung Agenesis Sprengel Deformity Ellis-Van Creveld Syndrome Microphthalmia Syndromic 9 Systemic Onset Juvenile Idiopathic Arthritis Emanuel Syndrome Neiman Pick C (with lung involvement) Thoracic Dysplasia Hydrocephalus Syndrome Familial Cryoglobulinemia Niemann-Pick Disease Type B Thoracomelic Dysplasia Familial Hypersensitivity Pneumonitis Nocardiosis Thyroglossal Tract Cyst Familial Hypocalciuric Hypercalcemia Type 2 Novak Syndrome Tracheobronchopathia Osteoplastica Familial Hypocalciuric Hypercalcemia Type 3 Occipital Horn Syndrome Wilson-Mikity Syndrome Feingold Syndrome Orofaciodigital Syndrome 4 Wolf-Hirschhorn Syndrome Fetal Akinesia Deformation Sequence PAGOD Syndrome Wrinkly Skin Syndrome Froster-Huch Syndrome Pallister-Killian Mosaic Syndrome Young Syndrome Game Friedman Paradice Syndrome Pentalogy of Cantrell 1 Rare Disease Term Date/Day Board Number / Time Abstract Number and Title Session ID and Title Location ABCA3 Mutations Monday, 706 2:15 - 4:15 PM A3851 Interminate Differentiation of Peripheral Respiratory Epithelial Cells B109: Alveolar Epitelial Cell Plasticity in Injury and Mile High Ballroom 1 A-B (Lower May 18th Poster Viewing 2:15 - 3:00 PM in Idiopathic Pulmonary Fibrosis (IPF) Fibrosis Level); CCC Discussion 3:00 - 4:15 PM Wednesday, 117 9:30 - 11:30 AM A5469 Multiplexed Direct Genomic Selection to Identify Genetic Variation D23: Pediatric Rare Diseases and Lung Development Room 102/104/106 (Street May 20th Poster Viewing 9:30 - 10:15 AM in Surfactant-Associated Genes Among Infants and Children with Level); CCC Discussion 10:15 - 11:30 AM Respiratory Distress Syndrome and Childhood Interstital Lung Disease (chILD) Wednesday, 101 9:30 - 11:30 AM A5453 Whole Exome Sequencing Identifies Chemokine Receptor 2 (CCR2) D23: Pediatric Rare Diseases and Lung Development Room 102/104/106 (Street May 20th Poster Viewing 9:30 - 10:15 AM as a Novel Gene for Children’s Interstital Lung Disease (chILD) Level); CCC Discussion 10:15 - 11:30 AM Wednesday, Oral 2:45 PM A6088 Building the Conducting Airways and Alveolar Gas Exchange Region D96: Lung Development and Neonatal Lung Disease Room 201/203 (Street Level); May 20th 1:30 - 3:30 PM of the Primate Lung CCC Acute Eosinophilic Pneumonia Sunday, P761 9:30 AM - 4:15 PM A1396 Smoking Related Small Airway Involvement Presenting as Diffuse A35: I've Got a Feeling We're Going to Solve This One: Area G; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM Multicystic Lung Disease: A New Lymphangioleiomyomatosis Mimic Insights Into Lymphangioleiomyomatosis CCC Sunday, P351 9:30 AM - 4:15 PM A1496 Acute Eosinophilic Pneumonia with Respiratory Failure Induced by A38: Tell Me What You See: Atypical Presentations Area D; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM ‘Bonzai’ (Synthetic Cannabinoid) Inhalation of ILD CCC Sunday, P359 9:30 AM - 4:15 PM A1504 Acute Fibrinous and Organizing Pneumonia – Is Smoking a A38: Tell Me What You See: Atypical Presentations Area D; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM Predisposing Factor? of ILD CCC Sunday, P331 9:30 AM - 4:15 PM A1476 Idiopathic Chronic Eosinophilic Pneumonia – A Diagnostic A38: Tell Me What You See: Atypical Presentations Area D; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM Conundrum, of ILD CCC Sunday, P336 9:30 AM - 4:15 PM A1481 If It Looks Like Asthma and It Sounds Like Asthma, It Might Be A38: Tell Me What You See: Atypical Presentations Area D; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM Chronic Eosinophilic Pneumonia of ILD CCC Sunday, P843 9:30 AM - 4:15 PM A1533 Daptomycin-Induced Acute Eosinophilic Pneumonia A40: A Hard Day's Night: Drug Induced Lung Disease Area G; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM CCC Sunday, P842 9:30 AM - 4:15 PM A1532 Meropenem: The New Culprit in Eosinophilic Lung Diseases A40: A Hard Day's Night: Drug Induced Lung Disease Area G; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM CCC 2 Rare Disease Term Date/Day Board Number / Time Abstract Number and Title Session ID and Title Location Sunday, P859 9:30 AM - 4:15 PM A1549 Progesterone Induced Eosinophilic Pneumonia: A Rare Occurrence A40: A Hard Day's Night: Drug Induced Lung Disease Area G; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM CCC Sunday, P1120 9:30 AM - 4:15 PM A1661 Daptomycin a Pulmonary Foe A44: Infectious Disease Challenges in the ICU Area J; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM CCC Sunday, P748 9:30 AM - 4:15 PM A1899 A Case of Radiotherapy Associated Eosinophilic Pneumonia A49: Pulmonary Infections: Case Studies (Fungal and Area F; Hall A-B (Upper Level); May 17th Poster Viewing 11:30 AM - 1:15 PM Other)
Load more

Recommended publications
  • ICD-10-CM Expert for SNF, IRF, and LTCH the Complete Official Code Set Codes Valid from October 1, 2018 Through September 30, 2019
    EXPERT 2019 ICD-10-CM Expert for SNF, IRF, and LTCH The complete official code set Codes valid from October 1, 2018 through September 30, 2019 Power up your coding optum360coding.com ITSN_ITSN19_CVR.indd 1 12/4/17 2:54 PM Contents Preface ................................................................................ iii ICD-10-CM Index to Diseases and Injuries .......................... 1 ICD-10-CM Official Preface ........................................................................iii Characteristics of ICD-10-CM ....................................................................iii ICD-10-CM Neoplasm Table ............................................ 331 What’s New for 2019 .......................................................... iv ICD-10-CM Table of Drugs and Chemicals ...................... 349 Official Updates ............................................................................................iv Proprietary Updates ...................................................................................vii ICD-10-CM Index to External Causes ............................... 397 Introduction ....................................................................... ix ICD-10-CM Tabular List of Diseases and Injuries ............ 433 History of ICD-10-CM .................................................................................ix Chapter 1. Certain Infectious and Parasitic Diseases (A00-B99) .........................................................................433 How to Use ICD-10-CM Expert for Skilled Nursing Chapter
    [Show full text]
  • Café Au Lait Spots As a Marker of Neuropaediatric Diseases
    Mini Review Open Access J Neurol Neurosurg Volume 3 Issue 5 - May 2017 DOI: 10.19080/OAJNN.2017.03.555622 Copyright © All rights are reserved by Francisco Carratalá-Marco Café Au Lait Spots as a Marker of Neuropaediatric Diseases Francisco Carratalá-Marco1*, Rosa María Ruiz-Miralles2, Patricia Andreo-Lillo1, Julia Dolores Miralles-Botella3, Lorena Pastor-Ferrándiz1 and Mercedes Juste-Ruiz2 1Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain 2Paediatric Department, University Hospital of San Juan de Alicante, Spain 3Dermatology Department, University Hospital of San Juan de Alicante, Spain Submission: March 22, 2017; Published: May 10, 2017 *Corresponding author: Francisco Carratalá-Marco, Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain, Tel: ; Email: Abstract Introduction: want to know in which The measure,Café au lait the spots presence (CALS) of isolated are shown CALS in representsthe normal a population risk factor forwithout neurological pathological disease. significance, although they could also be criteria for some neurologic syndromes. Unspecific association with general neurologic illnesses has been less frequently described. We Patients and methods: We set up an observational transversal study of cases, patients admitted for neuropaediatric reasons (NPP; n=49) excluding all the patients suffering from neurologic illnesses associated to CALS, and controls, a hospital simultaneously admitted pediatric population for non-neurologic causes (CP; n=101) since October 2012 to January 2013. The data were collected from the clinical reports at admission, and then analyzed by SPSS 22.0 statistical package, and the Stat Calc module of EpiInfo 7.0, following the ethics current rules of the institution for observational studies.
    [Show full text]
  • EFFECTIVE NEBRASKA DEPARTMENT of 01/01/2017 HEALTH and HUMAN SERVICES 173 NAC 1 I TITLE 173 COMMUNICABLE DISEASES CHAPTER 1
    EFFECTIVE NEBRASKA DEPARTMENT OF 01/01/2017 HEALTH AND HUMAN SERVICES 173 NAC 1 TITLE 173 COMMUNICABLE DISEASES CHAPTER 1 REPORTING AND CONTROL OF COMMUNICABLE DISEASES TABLE OF CONTENTS SECTION SUBJECT PAGE 1-001 SCOPE AND AUTHORITY 1 1-002 DEFINITIONS 1 1-003 WHO MUST REPORT 2 1-003.01 Healthcare Providers (Physicians and Hospitals) 2 1-003.01A Reporting by PA’s and APRN’s 2 1-003.01B Reporting by Laboratories in lieu of Physicians 3 1-003.01C Reporting by Healthcare Facilities in lieu of Physicians for 3 Healthcare Associated Infections (HAIs) 1-003.02 Laboratories 3 1-003.02A Electronic Ordering of Laboratory Tests 3 1-004 REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: 3 LISTS AND FREQUENCY OF REPORTS 1-004.01 Immediate Reports 4 1-004.01A List of Diseases, Poisonings, and Organisms 4 1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible 5 Bioterroristic Attacks 1-004.02 Reports Within Seven Days – List of Reportable Diseases, 5 Poisonings, and Organisms 1-004.03 Reporting of Antimicrobial Susceptibility 8 1-004.04 New or Emerging Diseases and Other Syndromes and Exposures – 8 Reporting and Submissions 1-004.04A Criteria 8 1-004.04B Surveillance Mechanism 8 1-004.05 Sexually Transmitted Diseases 9 1-004.06 Healthcare Associated Infections 9 1-005 METHODS OF REPORTING 9 1-005.01 Health Care Providers 9 1-005.01A Immediate Reports of Diseases, Poisonings, and Organisms 9 1-005.01B Immediate Reports of Clusters, Outbreaks, or Unusual Events, 9 Including Possible Bioterroristic Attacks i EFFECTIVE NEBRASKA DEPARTMENT OF
    [Show full text]
  • Mediastinitis and Bilateral Pleural Empyema Caused by an Odontogenic Infection
    Radiol Oncol 2007; 41(2): 57-62. doi:10.2478/v10019-007-0010-0 case report Mediastinitis and bilateral pleural empyema caused by an odontogenic infection Mirna Juretic1, Margita Belusic-Gobic1, Melita Kukuljan3, Robert Cerovic1, Vesna Golubovic2, David Gobic4 1Clinic for Oral and Maxillofacial Surgery, 2Clinic for Anaesthesiology and Reanimatology, 3Department of Radiology, 4Clinic for Internal Medicine, Clinical hospital, Rijeka, Croatia Background. Although odontogenic infections are relatively frequent in the general population, intrathoracic dissemination is a rare complication. Acute purulent mediastinitis, known as descending necrotizing mediastin- itis (DNM), causes high mortality rate, even up to 40%, despite high efficacy of antibiotic therapy and surgical interventions. In rare cases, unilateral or bilateral pleural empyema develops as a complication of DNM. Case report. This case report presents the treatment of a young, previously healthy patient with medias- tinitis and bilateral pleural empyema caused by an odontogenic infection. After a neck and pharynx re-inci- sion, and as CT confirmed propagation of the abscess to the thorax, thoracotomy was performed followed by CT-controlled thoracic drainage with continued antibiotic therapy. The patient was cured, although the recognition of these complications was relatively delayed. Conclusions. Early diagnosis of DNM can save the patient, so if this severe complication is suspected, thoracic CT should be performed. Key words: mediastinitis; empyema, pleural; periapical abscess – complications Introduction rare complication of acute mediastinitis.1-6 Clinical manifestations of mediastinitis are Acute suppurative mediastinitis is a life- frequently nonspecific. If the diagnosis of threatening infection infrequently occur- mediastinitis is suspected, thoracic CT is ring as a result of the propagation of required regardless of negative chest X-ray.
    [Show full text]
  • Federal Register/Vol. 69, No. 194/Thursday, October 7, 2004
    Federal Register / Vol. 69, No. 194 / Thursday, October 7, 2004 / Rules and Regulations 60083 Regulations Branch, Office of drawback requested on the drawback war are decided fairly, consistently, and Regulations and Rulings, U.S. Customs entry. This is determined as follows: based on all available medical and Border Protection. However, * * * * * information concerning the diseases personnel from other offices I 4. In § 191.171, a new paragraph (c) is associated with detention or internment participated in its development. added to read as follows: as a prisoner of war. DATES: List of Subjects in 19 CFR Part 191 This interim final rule is § 191.171 General; drawback allowance. effective October 7, 2004. Comments Claims, Commerce, CBP duties and * * * * * must be received on or before November inspection, Drawback. (c) Merchandise processing fees. In 8, 2004. cases where the requirements of Amendments to the Regulations ADDRESSES: Written comments may be paragraph (b)(1) of this section have submitted by: mail or hand-delivery to I For the reasons stated above, part 191 been met, merchandise processing fees Director, Regulations Management of the CBP Regulations (19 CFR part 191) will be eligible for drawback. (00REG1), Department of Veterans is amended as follows: Approved: October 4, 2004. Affairs, 810 Vermont Ave., NW., Room Robert C. Bonner, 1068, Washington, DC 20420; fax to PART 191 — DRAWBACK Commissioner, U.S. Customs and Border (202) 273–9026; e-mail to I 1. The general authority citation for Protection. [email protected]; or, through part 191 continues to read as follows: Timothy E. Skud, http://www.Regulations.gov. Comments Deputy Assistant Secretary of the Treasury.
    [Show full text]
  • Hereditary Gingival Fibromatosiswith Hemophilia B
    Vol. 17, No ?. UDC 616.311.2:616.151.5 CODEN: ASCRBK 1983 YU ISSN: 0001—7019 Original paper Hereditary gingival fibromatosis with hemophilia B Ilija Škrinjarić, Miljenko Bačić and Zvonko Poje Department of Children’s and Preventive Dentistry, Department of Periodontology and Department of Orthodontics, Faculty of Dentistry, University of Zagreb Received, February 7, 1983 Summary This work presents a case report of a generalized form of hereditary gin­ gival fibromatosis with hemophilia B as an accompanying disease. In the family of proband, consisting of 28 members, fibromatosis was present in 9 (4 males and 5 females). The pedigree analysis confirmed that gingival fibro­ matosis was transmited through three generations as an autosomal dominant trait. Neither proband, nor any other family member, showed other abnorma­ lities. Blood coagulation tests reveald hemophilia B (Christmas disease) in the proband. The coagulogram showed prolonged kaolin cephalin time (50 se­ conds) and low concentration of factor IX (F IX 18%). The case report sug­ gests that hemophilia B should be included in the list of diseases associated with gingival fibromatosis. Key words: gingival fibromatosis, hemophilia B Hereditary gingival fibromatosis manifests as an isolated trait, accompanied by other abnormalities or disease, or as a symptom of a specific syndrome. The most common clinical abnormalities associated with gingival fibromatosis are hypertrichosis, epilepsy, mental retardation, and defects of the eye, ear, nose, skeleton and nails (Fletcher1, Gorlin et a I.2, Jorgenson and Cocker3). Isolated gingival fibromatosis without other abnormalities is considered a special entity which differs from the fibromatosis accompanied by hypertrichosis, epilepsy or mental retardation (Cohen4).
    [Show full text]
  • Failure to Wean Caused by Cryptogenic Fibrosing Pleuritis and Bilateral Lung Trapping. Case Report*
    RBTI Relato DE CASO 2007:19:4:504-508 Failure to Wean Caused by Cryptogenic Fibrosing Pleuritis and Bilateral Lung Trapping. Case Report* Falência do Desmame em Paciente com Fibrose Pleural Idiopática e Trapping Pulmonar Bilateral. Relato de Caso Elsemiek Verweel1, Jos le Noble, PhD1, Christine Groeninx-van Zoelen1, Alex Maat2, Willy Thijsse1, Patricia Gerritsen1, Jan Bakker, PhD3 RESUMO Unitermos: decorticação pleural, fibrose pleural, fibro- se pulmonar, Fibrotórax Idiopático. JUSTIFICATIVA E OBJETIVOS: Fibrose pleural idiopá- tica é uma doença rara e pode afetar ambos pulmões SUMMARY já desde uma idade precoce. O achado mais comum na fibrose pleural idiopática é uma restrição pulmonar BACKGROUND AND OBJECTIVES: Cryptogenic fi -- grave que pode levar a um quadro de falência respira- brosing pleuritis is an extremely rare disease, which tória e hipoxemia. can affect both lungs from a very young age. The most RELATO DO CASO: Paciente do sexo masculino, 26 common finding is severe lung restriction resulting in anos, internado com reagudização de insuficiência both hypoxemic and ventilatory failure. respiratória crônica e submetido à ventilação mecâni- CASE REPORT: Male patient, 26 year old with acu- ca prolongada. Após intensa investigação e uma apre- te deterioration of chronic respiratory failure. Follo- sentação clínica atípica, foi estabelecido o diagnóstico wing admission prolonged mechanical ventilation de fibrose pleural idiopática associado à fibrose pul- was necessary. An atypical clinical presentation monar. made the diagnosis difficult, but eventually cryp- CONCLUSÕES: O prognóstico de pacientes com fi- togenic fibrosing pleuritis and lung fibrosis were brose pleural idiopática é extremamente ruim, particu- established. larmente em fase avançada da doença.
    [Show full text]
  • Differentiation of Lung Cancer, Empyema, and Abscess Through the Investigation of a Dry Cough
    Open Access Case Report DOI: 10.7759/cureus.896 Differentiation of Lung Cancer, Empyema, and Abscess Through the Investigation of a Dry Cough Brittany Urso 1 , Scott Michaels 1, 2 1. College of Medicine, University of Central Florida 2. FM Medical, Inc. Corresponding author: Brittany Urso, [email protected] Abstract An acute dry cough results commonly from bronchitis or pneumonia. When a patient presents with signs of infection, respiratory crackles, and a positive chest radiograph, the diagnosis of pneumonia is more common. Antibiotic failure in a patient being treated for community-acquired pneumonia requires further investigation through chest computed tomography. If a lung mass is found on chest computed tomography, lung empyema, abscess, and cancer need to be included on the differential and managed aggressively. This report describes a 55-year-old Caucasian male, with a history of obesity, recovered alcoholism, hypercholesterolemia, and hypertension, presenting with an acute dry cough in the primary care setting. The patient developed signs of infection and was found to have a lung mass on chest computed tomography. Treatment with piperacillin-tazobactam and chest tube placement did not resolve the mass, so treatment with thoracotomy and lobectomy was required. It was determined through surgical investigation that the patient, despite having no risk factors, developed a lung abscess. Lung abscesses rarely form in healthy middle-aged individuals making it an unlikely cause of the patient's presenting symptom, dry cough. The patient cleared his infection with proper management and only suffered minor complications of mild pneumoperitoneum and pneumothorax during his hospitalization. Categories: Cardiac/Thoracic/Vascular Surgery, Infectious Disease, Pulmonology Keywords: lung abscess, empyema, lung infection, pneumonia, thoracotomy, lobectomy, pulmonology, respiratory infections Introduction Determining the etiology of an acute dry cough can be an easy diagnosis such as bronchitis or pneumonia; however, it can also develop from other etiologies.
    [Show full text]
  • DIAGNOSIS and TREATMENT of BRUCELLOSIS (Undulant Fever)
    DIAGNOSIS AND TREATMENT OF BRUCELLOSIS (Undulant Fever) CHARLES L. HARTSOCK, M.D. Not only the treatment but also the diagnosis of undulant fever are far from being satisfactory, although many types of therapy are being tried and critically evaluated. Because of the tremendous scope of the disease, frequent discussions and reappraisals of our ideas about bru- cellosis will be absolutely essential for some time. Some physicians more or less disregard brucellosis and even scoff at the chronic phase of this new intruder in the realm of human disease. Others are overenthusi- astic and attempt to explain many vague and indefinite problems upon the basis of chronic brucellosis without sufficient evidence. Still other physicians have lost their original enthusiasm and have reverted to the first viewpoint, probably because of the great difficulty in coping with the caprices and vagaries of this disease and the marked uncertainties in diagnosis and treatment. Even though this disease is extremely protean and remarkably bizarre in its manifestations, it is a disease of known causative organism to which the generic term of brucella has been given. The original infection in man was traced to the drinking of goat's milk on the Island of Malta, and for many years this disease was known as Malta fever. Because of the undulating character of the fever with a tendency for remissions and recurrences, it was later called undulant fever which proved to be a very poor description of the febrile reaction in many instances. Brucellosis is the more specific term derived from the organism causing the disease. Three strains of the brucella organism have been isolated and named for their respective hosts: b.
    [Show full text]
  • 20) Thyrotoxicosis
    1 Міністерство охорони здоров’я України Харківський національний медичний університет Кафедра Внутрішньої медицини №3 Факультет VI по підготовці іноземних студентів ЗАТВЕРДЖЕНО на засіданні кафедри внутрішньої медицини №3 «29» серпня 2016 р. протокол № 13 Зав. кафедри _______д.мед.н., професор Л.В. Журавльова МЕТОДИЧНІ ВКАЗІВКИ для студентів з дисципліни «Внутрішня медицина (в тому числі з ендокринологією) студенти 4 курсу І, ІІ, ІІІ медичних факультетів, V та VI факультетів по підготовці іноземних студентів Тиреотоксикоз. Клінічні форми, діагностика, лікування. Пухлини щитоподібної залоз та патологія при щитоподібних залоз Харків 2016 2 Topic – «Thyrotoxicosis. Clinical forms, diagnostic, treatment. Tumors of thyreoid gland and pathology of parathyroid glands» 1.The number of hours - 5 Actuality: Thyroid gland disease is one of the most popular in Ukraine affect patients of working age, degrade the quality of life and reduce its duration. Aim: 1. To learn the method of determining the etiologic factors and pathogenesis of diffuse toxic goiter. Work out techniques of palpation of the thyroid gland. 2. To familiarize students with the classifications of goiter by OV.Nikolaєv (1955 г.) And WHO (1992 г.). 3. To distinguish a typical clinical picture of diffuse toxic goiter (DTG). 4. To acquainte with the atypical clinical variants of diffuse toxic goiter. 5. To acquaint students with the possible complications of DTG. 6. To determine the basic diagnostic criteria for Graves' disease 7. To make a plan to examinate patients with Graves' disease. 8. Analysis of the results of laboratory and instrumental studies, which are used for the diagnosis of DTG. 9. Differential diagnosis between DTG and goiter 10. Technology of formulation of the diagnosis of DTG and goiter.
    [Show full text]
  • Pediatric Pulmonology
    Received: 27 October 2019 | Accepted: 6 January 2020 DOI: 10.1002/ppul.24654 ORIGINAL ARTICLE: IMAGING Lung ultrasound—a new diagnostic modality in persistent tachypnea of infancy Emilia Urbankowska MD1 | Tomasz Urbankowski MD, PhD2 | Łukasz Drobczyński MD3 | Matthias Griese MD, PhD4 | Joanna Lange MD, PhD1 | Michał Brzewski MD, PhD5 | Marek Kulus MD, PhD1 | Katarzyna Krenke MD, PhD1 1Department of Pediatric Pneumonology and Allergy, Medical University of Warsaw, Abstract Warsaw, Poland Lung ultrasound (LUS) has been increasingly used in diagnosing and monitoring of 2Department of Internal Medicine, various pulmonary diseases in children. The aim of the current study was to evaluate Pneumonology and Allergy, Medical University of Warsaw, Warsaw, Poland its usefulness in children with persistent tachypnea of infancy (PTI). This was a 3Pediatric Radiology Department, Jan Polikarp controlled, prospective, cross‐sectional study that included children with PTI and Brudziński Pediatric Hospital, Warsaw, Poland healthy subjects. In patients with PTI, LUS was performed at baseline and then after 6 4Department of Pediatric Pneumology, Dr. von Hauner Children's Hospital, Ludwig‐ and 12 months of follow‐up. Baseline results of LUS were compared to (a) baseline Maximilians University, German Centre for high‐resolution computed tomography (HRCT) images, (b) LUS examinations in Lung Research (DZL), Munich, Germany ‐ 5Department of Pediatric Radiology, Medical control group, and (c) follow up LUS examinations. Twenty children with PTI were University of Warsaw, Warsaw, Poland enrolled. B‐lines were found in all children with PTI and in 11 (55%) control subjects ‐ Correspondence (P < .001). The total number of B lines, the maximal number of B lines in any Katarzyna Krenke, Department of Pediatric intercostal space, the distance between B‐lines, and pleural thickness were Pneumonology and Allergy, Medical University of Warsaw, Żwirki i Wigury 63A, significantly increased in children with PTI compared to controls.
    [Show full text]
  • Osteoporosis in Premenopausal Women: a Clinical Narrative Review by the ECTS and the IOF
    This is a repository copy of Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/162028/ Version: Accepted Version Article: Pepe, J., Body, J.-J., Hadji, P. et al. (8 more authors) (2020) Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. The Journal of Clinical Endocrinology & Metabolism. ISSN 0021-972X https://doi.org/10.1210/clinem/dgaa306 This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Clinical Endocrinology and Metabolism following peer review. The version of record Jessica Pepe, Jean-Jacques Body, Peyman Hadji, Eugene McCloskey, Christian Meier, Barbara Obermayer-Pietsch, Andrea Palermo, Elena Tsourdi, M Carola Zillikens, Bente Langdahl, Serge Ferrari, Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF, The Journal of Clinical Endocrinology & Metabolism, dgaa306 is available online at: https://doi.org/10.1210/clinem/dgaa306 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request.
    [Show full text]